Microviable Therapeutics will be attending LSX Inv€$tival Showcase Claudio Hidalgo, PhD, cofounder and CEO and Noelia Martínez, PhD, cofounder and R&D Director at Microviable Therapeutics, will be attending LSX Inv€$tival Showcase in London on November [...]
World Microbiome Day is here another year!! The World Microbiome Day was created for raising awareness about the fascinating world of microbiomes and their impact on our health and the environment. The human microbiome is [...]
Microviable Therapeutics will be attending Bio International Convention 2025 in Boston Claudio Hidalgo, PhD., cofounder and CEO, will be attending the BIO International Convention 2025 event, taking place in Boston during June 16th-19th. This four-day [...]
Microviable Therapeutics joins the European Microbiome Innovation for Health (EMIH) EMIH is an independent European coalition, a public and private initiative, and a non-profit organization aiming to ensure that microbiome-based medical innovations become a public [...]
Genetic Engineering and Biotechnolgy News is one of the leading journals in biotechnology, showcasing groundbreaking technologies and the latest advanced in the biotech field. Check out the latest article published at the prestigious journal and [...]
Microviable Therapeutics will be at The Microbiome Times Partnering Forum taking place in Brussels on March 18-19th 2025. Claudio Hidalgo, PhD., cofounder and CEO, and David Ríos Covián, PhD., CTO will be attending The Microbiome [...]
Pilar Manrique, senior scientist at Microviable Therapeutics will be present at 9th Microbiome Microbiome Movement Summit taking place in Barcelona in January 28-30th 2025! The Summit explored the latest advances in microbiome science, where innovative [...]
Gijón, Spain, September 23rd 2024 – Microviable Therapeutics, a biotech company developing novel biological drugs for infectious diseases and oncology, announced today the appointment of Mehdi Chouikh Skalli as Chief Financial Officer. Mehdi Chouikh has [...]
On September 24th, we join the global community in recognizing World Cancer Research Day (WCRD)—an international movement dedicated to highlighting the critical role of cancer research in driving breakthroughs for cancer control and treatment. This [...]
David Ríos Covián, Director of Technology Development at Microviable Therapeutics, will participate in the 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Particularly, David Rios will be present as [...]